Literature DB >> 16340638

Evaluation of intrapulmonary vascular dilatations with high-resolution computed thorax tomography in patients with hepatopulmonary syndrome.

Deniz Köksal1, Sabite Kaçar, Aydin S Köksal, Omaç Tüfekçioğlu, Fahrettin Küçükay, Sarper Okten, Nurgül Saşmaz, Kemal Arda, Burhan Sahin.   

Abstract

GOALS: We aimed to determine the role of thorax high-resolution computed tomography (HRCT) in demonstrating the pulmonary vasodilatation in patients with hepatopulmonary syndrome (HPS).
BACKGROUND: Traditionally, the presence of intrapulmonary vascular dilatations can be detected by using one of the three diagnostic modalities: contrast-enhanced echocardiography, technetium 99 m-labeled macroaggregated albumin scan, and pulmonary angiography. STUDY: The study group included 10 patients with HPS (Group 1), 12 patients with normoxemic cirrhosis (Group 2), and 12 healthy controls (Group 3). All of the subjects underwent conventional and HRCT of thorax. The diameters of pulmonary trunk, main pulmonary arteries, and right lower lobe basal segmental arteries were measured. The ratios of right lower lobe basal segmental pulmonary artery to bronchus diameter were calculated.
RESULTS: The mean diameters of the main pulmonary trunk, right and left main pulmonary arteries were not different between the groups. Mean diameters of right lower lobe basal segmental pulmonary arteries were significantly higher in Group 1 compared with Group 2 (P=0.01) and Group 3 (P=0.002). Mean right lower lobe basal segmental pulmonary artery to bronchus ratios were significantly higher in Group 1 compared with Group 2 (P=0.03) and Group 3 (P<0.001). Group 2 had significantly higher pulmonary artery to bronchus ratios than Group 3 (P<0.001).
CONCLUSIONS: Thorax HRCT may be helpful in the diagnosis of HPS by demonstrating the dilated peripheral pulmonary vessels or increased pulmonary artery to bronchus ratios in patients with liver disease and hypoxemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16340638     DOI: 10.1097/01.mcg.0000190775.57903.86

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  11 in total

Review 1.  Hepatopulmonary syndrome: What we know and what we would like to know.

Authors:  Israel Grilo-Bensusan; Juan Manuel Pascasio-Acevedo
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

Review 2.  Hepatopulmonary syndrome: update on pathogenesis and clinical features.

Authors:  Junlan Zhang; Michael B Fallon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-03       Impact factor: 46.802

Review 3.  Cirrhosis and hepatopulmonary syndrome.

Authors:  Gokhan Tumgor
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

4.  Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates.

Authors:  Michael B Fallon; Michael J Krowka; Robert S Brown; James F Trotter; Steven Zacks; Kari E Roberts; Vijay H Shah; Neil Kaplowitz; Lisa Forman; Keith Wille; Steven M Kawut
Journal:  Gastroenterology       Date:  2008-06-20       Impact factor: 22.682

5.  Unexplained cyanosis revealing hepatopulmonary syndrome in a child with asymptomatic congenital hepatic fibrosis: a case report.

Authors:  Atqah Abdul Wahab; Maryam Al-Mansoori; Mariam El-Hawli; Vishwanatha Kini
Journal:  J Med Case Rep       Date:  2013-04-29

Review 6.  Review article: Update on current and emergent data on hepatopulmonary syndrome.

Authors:  Stergios Soulaidopoulos; Evangelos Cholongitas; George Giannakoulas; Maria Vlachou; Ioannis Goulis
Journal:  World J Gastroenterol       Date:  2018-03-28       Impact factor: 5.742

Review 7.  Cardiac Imaging in Liver Transplantation Candidates: Current Knowledge and Future Perspectives.

Authors:  Yannis Dimitroglou; Constantina Aggeli; Alexandra Alexopoulou; Sophie Mavrogeni; Dimitris Tousoulis
Journal:  J Clin Med       Date:  2019-12-03       Impact factor: 4.241

Review 8.  Advances in Diagnostic Imaging of Hepatopulmonary Syndrome.

Authors:  Bi-Wei Luo; Zhi-Yong Du
Journal:  Front Med (Lausanne)       Date:  2022-01-10

9.  CT Scan Does Not Differentiate Patients with Hepatopulmonary Syndrome from Other Patients with Liver Disease.

Authors:  Yingming Amy Chen; Vikramaditya Prabhudesai; Helene Castel; Samir Gupta
Journal:  PLoS One       Date:  2016-07-06       Impact factor: 3.240

10.  Hepatopulmonary syndrome has low prevalence of pulmonary vascular abnormalities on chest computed tomography.

Authors:  Luciano Folador; Felipe S Torres; Juliana F Zampieri; Betina C Machado; Marli M Knorst; Marcelo B Gazzana
Journal:  PLoS One       Date:  2019-10-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.